Skip to main content
. Author manuscript; available in PMC: 2014 Jul 27.
Published in final edited form as: Amyloid. 2014 Jan 22;21(1):45–53. doi: 10.3109/13506129.2013.876400

Figure 6.

Figure 6

Biodistribution of 125I-p5R as for Figure 5 except that mice were not treated (white bars) or treated (gray bars) with clodronate liposomes 5 d after AEF and euthanized 2 weeks (n=10, top panel) or 6 weeks (n=5, bottom panel) post-AEF. Data are shown as % injected dose/gram of wet tissue ± SD For the 2 week data (top panel) there was a significant difference in 125I-p5R accumulation in liver and spleen (p=0.007 and 0.006, respectively). In contrast at 6 weeks post-AEF injection there was no significant difference in 125I-p5R accumulation in either liver or spleen (p= 0.646 and 0.201, respectively).